Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 17 von 363
Cytometry. Part B, Clinical cytometry, 2015-01, Vol.88 (1), p.69-73
2015
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
A case of CD138−/CD19+/CD4+ IgD plasma cell leukemia
Ist Teil von
  • Cytometry. Part B, Clinical cytometry, 2015-01, Vol.88 (1), p.69-73
Ort / Verlag
United States: Wiley Subscription Services, Inc
Erscheinungsjahr
2015
Quelle
Free E-Journal (出版社公開部分のみ)
Beschreibungen/Notizen
  • Background Plasma cell leukemia (PCL) is an uncommon and aggressive disease caused by the clonal proliferation of atypical plasma cells with phenotypical abnormalities similar to those seen in multiple myeloma (MM), although at different rates. Here, we report a case of IgD PCL with a very unusual CD138−/CD19+/CD4+ phenotype. Methods Peripheral blood and bone marrow samples from a 37‐year‐old patient afflicted by an aggressive plasma cell dyscrasia were examined and analyzed by conventional morphology, flow cytometry, and immunohistochemistry. Results Analysis of peripheral blood fulfilled criteria for PCL (more than 20% and more than 2 × 10e9 cells/L). However, flow cytometry and immunohistochemistry phenotyping revealed that the cells were CD138−/CD38+/CD19+/CD4+/CD56−/CD117−. Conclusions PCL is diagnosed on peripheral blood smear. Immunophenotyping is a tool that can be helpful in diagnosing difficult cases but its atypical findings should not prevent the appropriate PCL diagnosis in clinically and morphologically unquestionable cases. © 2014 International Clinical Cytometry Society

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX